Combination of Atorvastatin with Sulindac or Naproxen Profoundly Inhibits Colonic Adenocarcinomas by Suppressing the p65/ -Catenin/Cyclin D1 Signaling Pathway in Rats

Published 2011 View Full Article

Authors

Keywords

Journal

Cancer Prevention Research

Volume 4, Issue 11, Pages 1895-1902

Publisher

American Association for Cancer Research (AACR)

Online

2011-07-16

DOI

10.1158/1940-6207.capr-11-0222

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Cancer Prevention Research

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer